Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Scientists studied one million immune cells and found clues to future disease risk (opens in a new tab)

news-medical.net · 2026-10-22

Short answerEvidenceSource

Short answer

Not assessed

Check incomplete.

We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Source study identified.

A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.

View article claims
3
Then inspect each claim

Evidence layer

Claim by claim

A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.

Claim 1 of 8Not checkedA recent study published in Nature Immunology presents a single-cell atlas of human neutrophils, offering new insights into how these immune cells behave in health and disease.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 2 of 8Not checkedThe researchers linked neutrophil gene activity patterns to cancer outcomes, metabolic health, the risk of death over the long term, and mortality risk among people with acute illness at hospital presentation.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 3 of 8Not checkedThe study brought together data on approximately one million human neutrophils from 43 scRNA-seq datasets comprising 781 samples across more than 20 tissues and diseases.View evidenceHide evidence

As statedapproximately one million human neutrophils; 43 datasets; 781 samples; more than 20 tissues and diseases

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 4 of 8Not checkedAnalysis of 17,023 bulk blood transcriptomes across 40 datasets linked neutrophil-specific signatures to acute mortality, cancer outcomes, metabolic dysfunction, and long-term all-cause mortality.View evidenceHide evidence

As stated17,023 bulk blood transcriptomes across 40 datasets

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 5 of 8Not checkedSeveral immature and degranulating neutrophil signatures were linked to greater disease severity and mortality, whereas CD74-related signatures were linked to better outcomes.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 6 of 8Not checkedAn exploratory subgroup analysis of the SAVE-MORE trial found that anakinra treatment was associated with significantly lower mortality within 28 or 30 days among hospitalized COVID-19 patients with low baseline IL1B gene expression.View evidenceHide evidence

As statedlower mortality within 28 or 30 days

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 7 of 8Not checkedSelected neutrophil gene signatures were linked to less favorable metabolic indicators, diabetes, and a greater risk of death from any cause.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 8 of 8Not checkedThe authors conclude that neutrophil profiles and routine counts may help identify patients at increased risk, but prospective studies are needed before clinical application.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

A single-cell atlas of human neutrophils reveals neutrophil heterogeneity across health and disease

Nature Immunology · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 39 candidate papers

Selected

A single-cell atlas of human neutrophils reveals neutrophil heterogeneity across health and disease

Nature Immunology · 2026 · Crossref

Source (opens in a new tab)

And 33 more candidates considered.